Skip to content

Bullish Strategists Go Unheeded as Doctors Drive Market Moves

  • Consensus that variant won’t derail rally fails to calm nerves
  • Markets move on medical news, rather than strategy notes

Stock markets are once again at the mercy of news from the medical front, as a chorus of reassuring messages from strategists is failing to soothe investor concerns about omicron. 

JPMorgan Chase & Co., UBS Global Wealth Management and BlackRock’s Investment Institute are among those recommending that clients stay invested in equities with the rally set to continue. Markets, however, are much more interested in what epidemiologists, doctors and vaccine developers have to say.